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Abstract: HPLC profiling of phenolics in grape seed extracts revealed a prominent peak of an unknown
substance with concentrations up to 5.3%. Spectroscopic data allowed the identification of the
compound 1 as 1-(3′,4′-dihydroxyphenyl)-3-(2”,4”,6”-trihydroxyphenyl)-propan-2-ol. 1 is known
to be produced from catechin and epicatechin through anaerobic bacteria from human, as well
as the rat, intestines. It was hypothesized that the marc remaining after expression of juice from
grapes became infested during storage, resulting in the production of 1. Because compound 1 is
infrequently found in nature and has never been found in grape seeds, its presence may be considered
a marker of an unwanted anaerobic bacterial process occurring during production. The antioxidant
potential of 1 was determined by DPPH, ABTS, and FRAP (ferric reducing antioxidant power) assays
and compared to the potential of the following compounds: phloroglucine, pyrogallol, gallic acid,
catechin, and epicatechin. Furthermore, it was established that 1 significantly reduced guinea pig
ileum contraction induced by histamine.
Keywords: 1-(3′,4′-dihydroxyphenyl)-3-(2”,4”,6”-trihydroxyphenyl)-propan-2-ol; 3,4-diHPP-2-ol;
procyanidins; grape seed extract; phenols; antioxidant activity; antispasmodic effect; marker for grape
seed extract
1. Introduction
Proanthocyanidins are present in a wide variety of plant-derived foods and beverages, such as
apples, grapes, chocolate, peanuts, and wine. A great variety of health-related properties have been
reported for proanthocyanidins, including antioxidant, antiviral, anti-inflammatory, insulin-like activity,
and anti-tumor activity. Antioxidant and cardioprotective properties of proanthocyanidins have gained
considerable attention recently [1–3]. Grape seed proanthocyanidins (GSPs) comprise of dimers,
trimers, tetramers, and higher oligomers of catechins and/or epicatechins, as described previously by
Chen et al. [4]. In addition to the variability related to the number of connected epicatechin/catechin
units, a specific type of connectivity, and chain branching, proanthocyanidins may also contain ester
groups of gallic acid. The B-type procyanidins present in GSE (grape seed extract) contain mainly the
4β→ 8’ bond and occasionally the 4β→ 6’ C–C bond. GSPs display a range of beneficial biological
effects, including anti-carcinogenic, vasoprotective, antioxidant, and neuroprotective qualities [5–8].
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Fundamental concerns in quality control arise from the increasing use and the complex chemical
composition of GSE. As there are no clear standardization criteria for its quality, the composition of
commercial GSE supplements is subject to large variation [7].
The bioavailability, as well as bioactivity, of dietary polyphenols, are dependent on the activity
of the colonic microbiota that, in turn, is largely influenced by their degree of polymerization (DP).
Microbial catabolism in the colon is especially important for absorbed monomeric flavan-3-ols that
reach the colon through bile and for molecules with a DP > 2, which present poor absorption
in the small intestine [9]. Recently, it was reported that after oral administration of [14C]
labeled procyanidin B2, 63% of total radioactivity was excreted via urine, indicating that the
majority of the compound was degraded by gut microbiota [10]. The catabolism of flavan-3-ol
monomers and polymers starts with the reductive cleavage of the heterocyclic C-ring, producing
intermediate metabolite 1-(3′,4′-dihydroxyphenyl)-3-(2”,4”,6”-trihydroxyphenyl)-propan-2-ol (1).
Subsequently, two metabolites are formed from 1: 5-(3′,4′-dihydroxyphenyl)-γ-valerolactone
and 4-hydroxy-5-(3′,4′-dihydroxyphenyl)-valeric acid, which, after a series of decarboxylation,
dehydroxylation, and oxidation reactions, result in a great variety of chemical structures corresponding
to phenylpropionic, phenylacetic, hydroxybenzoic acids, and simple phenols with different
hydroxylation patterns [3,11–13].
Although the health effects of the procyanidin microbial metabolites remain in many cases
incompletely understood, anti-inflammatory and antiproliferative activities of metabolites have been
reported. Further findings suggest that their residence time in the organism is sufficient to produce
local or systemic health effects [14,15].
There are only a handful of reports documenting the presence of 1 or the presence of other
structurally similar substances in plants. Rotundifolinol, quracol A and B, propterol I and II,
and virolanols II are examples of compounds isolated from plant material possessing similar structures
to 1 [16–20].
Because 1 has not been described as a native constituent of grape seeds, its presence at such
high concentrations must be interpreted as an artifact, likely resulting from the production process.
Furthermore, the literature contains no information about the antioxidant activity of 1. Therefore,
its antioxidant potential was determined by DPPH, ABTS, and FRAP (ferric reducing antioxidant
power) assays and compared to the potential of other closely related phenols, including phloroglucine,
pyrogallol, gallic acid, catechin, and epicatechin.
Several flavonoids have been shown to have concentration-dependent relaxant effects in smooth
muscle. Among them, (+) catechin has been shown to have an antispasmodic effect in rodents [21].
Moreover, Quracols A and B [18] are structurally similar to 1 and showed smooth muscle relaxation
properties; also, phloroglucine is a commercial muscle relaxant in France. Based on these considerations,
we evaluated 1 in a smooth muscle relaxing test.
2. Results and Discussion
In the present work, HPLC was performed on forty-six GSEs, acquired from domestic and
international producers, to evaluate their procyanidin pattern. The main peaks typically distinguished
in grape seed extract by reverse-phase (RP) HPLC belong to epicatechin, dimeric procyanidin B2,
catechin, as well as several other dimeric, trimeric, and tetrameric procyanidins accompanied by
their galloylated derivatives (Figure 1A). Observing procyanidins higher than DP 4 was difficult,
considering peak overlapping, a complex baseline, and their relatively low natural concentrations.
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Figure 1. HPLC chromatograms. (A) Typical reverse-phase (RP) HPLC chromatogram of 
Grape Seed Extract, showing flavanols and major procyanidin components. (B) RP HPLC 
of Grape Seed Extract, containing 3,4-diHPP-2-ol (1). 
In six samples, an unknown phenolic substance was observed, reaching 5.3% at its maximum 
(Figure 1B). The chromatograms (Figure 1A,B) revealed an inverse relationship between the peak 
area of 1 and the peak area of catechin, epicatechin, and procyanidins B2 and C1. 
Following chromatographic purification and spectral analysis using NMR, MS, and MS/MS 
experiments (Figure 2), the peak’s identity was attributed to 1-(3′,4′-dihydroxyphenyl)-3-(2″,4″,6″-
trihydroxyphenyl)-propan-2-ol (1). Both the NMR and MS spectra of 1 were in agreement with 
those previously published by Sánchez-Patán et al. [9], Meselhy et al. [22], Wang et al. [23], and 
Takagaki et al. [24]. 
Figure 1. HPLC chromatograms. (A) Typical reverse-phase (RP) HPLC chromatogram of Grape Seed
Extract, showing flavanols and major procyanidin components. (B) RP HPLC of Grape Seed Extract,
containing 3,4-diHPP-2-ol (1).
In six samples, an unknown phenolic substance was observed, reaching 5.3% at its maximum
(Figure 1B). The chromatograms (Figure 1A,B) revealed an inverse relationship between the peak area
of 1 and the peak area of catechin, epicatechin, and procyanidins B2 and C1.
Following chromatographic purification and spectral analysis using NMR, MS, and MS/MS
experiments (Figure 2), the peak’s identity was attributed to 1-(3′,4′-dihydroxyphenyl)-3-(2”,4”,6”-
trihydroxyphenyl)-propan-2-ol (1). Both the NMR and MS spectra of 1 were in agreement with those
previously published by Sánchez-Patán et al. [9], Meselhy et al. [22], Wang et al. [23], and Takagaki et al. [24].
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Figure 2. MS/MS spectrum of the (1), ion (m/z 291) in negative mode. 
So far, the presence of this compound originating from a plant source has been confirmed in 
one instance [16]. A few more reports exist on the presence of similar diarylpropane-2-ols of plant 
origin [17–20]. 
According to some authors, this compound is linked to the bacterial catabolism of monomeric 
flavan-3-ols ((+)-catechin, (−)-epicatechin, and (−)-epicatechin-3-O-gallate) [3,14,22,23]. A tentative 
pathway for microbial degradation of procyanidin dimers, leading to the formation of 1, is 
presented in Figure 3. 
 
Figure 3. Tentative pathway for microbial degradation of procyanidin dimers, leading to 
the formation of 1-(3′,4′-dihydroxyphenyl)-3-(2″,4″,6″-trihydroxyphenyl)-propan-2-ol (1). 
Many reports present that during incubation with anaerobic bacteria of fecal origin, 
(epi)catechin or its galloyl esters can be converted into 1 and its related analogs through enzymatic 
hydrogenation [9,11,14,22,23]. 
In one report, it was concluded that Lactobacillus plantarum IFPL935 facilitates a reductive 
cleavage in the C-ring of monomeric flavan-3-ols and their gallates, both in solutions containing 
pure compounds and in complex phenolic extracts, producing diphenylpropan-2-ol. However, the 
report states that A- and B-type procyanidins, as both individual compounds and in extracts, do not 
undergo the same cleavage, and, therefore, suggests that the resistance is not connected to the 
catabolism under the conditions used in this study [9]. According to literature, besides Lactobacillus 
plantarum IFPL935, both Eubacterium SDG-2 and Eggerthella lenta rK3 isolated from human feces are 
the only bacteria capable of producing diphenylpropan-2-ol from monomeric flavan-3-ols [23]. 
Also, studies performed in vitro by Takagaki et al. [24], and in vivo by Margalef et al. [25], show the 
biotransformation of GSPs by rat intestinal microbiota. Similarly, compound 1 is formed in the 
Figure 2. MS/MS spectrum of the (1), ion (m/z 291) in negative mode.
So far, the presence of this compound originating from a plant source has been confirmed
in one instance [16]. A few more reports exist on the presence of similar diarylpropane-2-ols of
plant origin [17–20].
According to some authors, this compound is linked to the bacterial catabolism of monomeric
flavan-3-ols ((+)-catechin, (−)-epicatechin, and (−)-epicatechin-3-O-gallate) [3,14,22,23]. A tentative
pathway for microbial degradation of procyanidin dimers, leading to the formation of 1, is presented
in Figure 3.
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Figure 3. Tentative pathway for microbial degradation of procyanidin dimers, leading to the formation
of 1-(3′,4′-dihydroxyphenyl)-3-(2”,4”,6”-t ihydroxyphenyl)-propan-2-ol (1).
Many reports present that during incubation with anaerobic bacteria of fecal origin, (epi)catechin or its
galloyl esters can be converted into 1 an its related analogs through enzymatic hydrogenati n [9,11,14,22,23].
In one report, it was concluded that Lactobacillus plantarum IFPL935 facilitates a red ctive cleavage
in the C-ring f monomeric flavan-3-ols and their gallates, both in solutions containing pure compounds
and in c mplex phenolic extracts, pro ucing diphenylpropan-2-ol. However, the report states that A-
and B-type procyanidins, as both individual compounds and in extracts, do ot undergo the same
cleavage, and, therefore, suggests t at the resistance is not connected to the catabolism under t e
conditions used in this study [9]. Accor i g to literature, besides Lactobacillus plantarum IFPL935,
both Eubacteriu SDG-2 and Eggerthella lenta rK3 isolated from hum feces are the only bacteria
capa le of pro ucing diphenylpropan-2-ol from monomeric flava -3- ls [23]. Also, studies performed
in vitro by Takagaki et al. [24], and in vivo by Margalef et al. [25], show the biotransf rmation of GSPs by
rat intestinal microbiota. Similarly, compound 1 is formed i the lahpet-so, a traditional post-fermented
tea f Myanmar pr duced under anaerobic conditions, and in the Japanese post-fermented tea produced
y anaerobic microbial fermentation of green tea [26].
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Although health effects of microbial metabolites have not been fully elucidated, antioxidative,
anti-inflammatory, antiproliferative, and antiplatelet aggregation properties have been described for
some polyphenol metabolites [9,14,15].
Our study shows that the presence of 1-(3′,4′-dihydroxyphenyl)-3-(2”,4”,6”-trihydroxyphenyl)-
propan-2-ol in GSE indicates the involvement of anaerobic bacteria during the production of GSE from
the grapes. Consequently, the bacteria reduce relative concentrations of epicatechin and catechin in
GSE, while they increase the concentration of 1. Therefore, compound 1 can be treated as a suitable
marker for the detection of unwanted bacterial processes.
ABTS, DPPH, and FRAP assays were performed to determine the antioxidant activity of 1 and
various related phenols.
Table 1 presents the results of the antioxidant activity of gallic acid, pyrogallol,
1-(3′,4′-dihydroxyphenyl)-3-(2”,4”,6”- trihydroxyphenyl)- propan-2-ol, epicatechin, catechin,
and phloroglucine together with Trolox that was used as a reference.
Table 1. Comparison of pure phenolic compounds in terms of their radical scavenging activities.
Compounds IC50 (µM)
a
ABTS Assay DPPH Assay
Gallic acid 214.2 ± 8.1 12.03 ± 0.84
Pyrogallol 232.3 ± 15.9 15.36 ± 2.56
1
3,4-diHPP-2-ol 168.1 ± 9.7 17.67 ± 2.16
Epicatechin 254.3 ± 14.2 18.10 ± 2.88
Catechin 265.2 ± 10.5 22.21 ± 2.09
Phloroglucine 372.9 ± 45.6 207.51 ± 16.6
Trolox 921.5 ± 61.7 29.00 ± 2.37
a Values are the means of three measurements (n = 3). [2,2’-azino-bis-(3-ethylbenzothiazoline-6-sulfonic acid)]
free radical scavenging activity assay (ABTS), (1,1-diphenyl-2-picrylhydrazyl) free radical scavenging activity
assay (DPPH).
It was found that all tested phenols were able to scavenge the ABTS•+ radical cation and
antioxidant activities measured at 6 minutes, expressed as IC50, which were relatively higher when
compared to Trolox. The IC50 value of 1 was the highest among all tested compounds. Similarly,
in the DPPH assay, the activities of phenols were higher compared to Trolox with the exception of
phloroglucine. The activity of 1 was slightly higher than epicatechin and catechin, but lower compared
to gallic acid and pyrogallol. In this assay, phloroglucine showed the weakest activity.
In the FRAP assay, all tested phenols possessed the ability to reduce Fe3+ to Fe2+, and their activity
was higher than that of Trolox (Figure 4) at the same concentration. The antioxidant activity of phenolic
substances in the FRAP assay depends on the number of hydroxyl groups. The antioxidant activity
was higher for phenolic substances compared to Trolox, where only one hydroxyl group reacted in
these experimental conditions.
During an in vitro smooth muscle relaxant assay for 1, the contractions induced by histamine
were significantly reduced by 55% in the presence of 1 at a concentration of 10 µM. It is known that
histamine-induced contraction of intestinal smooth muscle via stimulation of H1-receptors. The results
may suggest an antihistamine effect of the tested compound. The presence of the test compound did
not significantly alter the contractions of the small intestine after administration of carbachol or barium
chloride (Figure 5).
Molecules 2019, 24, 2466 6 of 11   x FOR PEER REVIEW    
 
 6
 
Figure 4. Antioxidant activity of various phenols determined via the FRAP (ferric 
reducing antioxidant power) assay. The concentration of the compounds was 0.01 mg/mL. 
During an in vitro smooth muscle relaxant assay for 1, the contractions induced by histamine 
were significantly reduced by 55% in the presence of 1 at a concentration of 10 µM. It is known that 
histamine-induced contraction of intestinal smooth muscle via stimulation of H1-receptors. The 
results may suggest an antihistamine effect of the tested compound. The presence of the test 
compound did not significantly alter the contractions of the small intestine after administration of 
carbachol or barium chloride (Figure 5). 
 
Figure 5. The spasmolytic effect of (1) 1-(3′,4′-dihydroxyphenyl)-3-(2″,4″,6″-
trihydroxyphenyl)-propan-2-ol (10 µM) during contractions induced by histamine (HIS) 
at 2 µM, carbachol (CCH) at 100 µM, and barium chloride (BaCl2) at 0.03 M. Results are 
expressed as the mean ± SEM (n = 6), * p <0.05 vs. histamine control contractions. 
3. Materials and Methods 
3.1. Chemical Reagents and Materials 
Samples of commercial grape seed extracts (GSEs) were obtained from domestic and 
international producers. Vouchers of commercially available GSEs have been deposited in the 
Planta Analytica (New Milford, CT, USA) facilities. Gallic acid, (+)-catechin, and (−)-epicatechin 
were obtained from Extrasynthèse (Lyon, France). Pyrogallol and phloroglucine were obtained 
from Fluka (Steinheim, Germany). Analytical grade organic solvents and HPLC grade water were 
purchased from Pharmco AAPER (Brookfield, CT, USA). 
re 4. Antioxidant ctivity of various phen ls determined via he FRAP (ferric reducing antioxidant
power) ass y. The co centration of the compou ds was 0.01 mg/mL.
Molecules 2019, 24, x FOR PEER REVIEW 6 of 11 
 
 6
 
Figure 4. Antioxidant activity of various phenols determined via the FRAP (ferric 
reducing antioxidant power) assay. The concentration of the compounds was 0.01 mg/mL. 
During an in vitro smooth muscle relaxant assay for 1, the contractions induced by histamine 
were significantly reduced by 55% in the presence of 1 at a concentration of 10 µM. It is known that 
histamine-induced contraction of intestinal smooth muscle via stimulation of H1-receptors. The 
results may suggest an antihistamine effect of the tested compound. The presence of the test 
compound did not significantly alter the contractions of the small intestine after administration of 
carbachol or barium chloride (Figure 5). 
 
Figure 5. The spasmolytic effect of (1) 1-(3′,4′-dihydroxyphenyl)-3-(2″,4″,6″-
trihydroxyphenyl)-propan-2-ol (10 µM) during contractions induced by histamine (HIS) 
at 2 µM, carbachol (CCH) at 100 µM, and barium chloride (BaCl2) at 0.03 M. Results are 
expressed as the mean ± SEM (n = 6), * p <0.05 vs. histamine control contractions. 
3. Materials and Methods 
3.1. Chemical Reagents and Materials 
Samples of commercial grape seed extracts (GSEs) were obtained from domestic and 
international producers. Vouchers of commercially available GSEs have been deposited in the 
Planta Analytica (New Milford, CT, USA) facilities. Gallic acid, (+)-catechin, and (−)-epicatechin 
were obtained from Extrasynthèse (Lyon, France). Pyrogallol and phloroglucine were obtained 
from Fluka (Steinheim, Germany). Analytical grade organic solvents and HPLC grade water were 
purchased from Pharmco AAPER (Brookfield, CT, USA). 
Figure 5. The spasmolytic effect of (1) 1-(3′,4′-dihydroxyphenyl)-3-(2”,4”,6”-trihydroxyphenyl)-propan-2-ol
(10 µM) during contractions induced by histamine (HIS) at 2 µM, carbachol (CCH) at 100 µM, and
barium chloride (BaCl2) at 0.03 M. Results are expressed as the mean ± SEM (n = 6), * p <0.05 vs.
histamine control contractions.
3. Materials and Methods
3.1. Chemical Reagents and Materials
Samples of commercial grape seed extracts (GSEs) were obtained from domestic and international
producers. Vouchers of commercially available GSEs have been deposited in the Planta Analytica
(New Milford, CT, USA) facilities. Gallic acid, (+)-catechin, and (−)-epicatechin were obtained from
Extrasynthèse (Lyo , France). Pyrogallol and phloroglucine were obtained from Fluka (Steinheim,
Germany). Analytical grade org nic solvents and HPLC grade water were purchased from Pharmco
AAPER (Brookfield, CT, USA).
3.2. Isolation of (1)
Ten grams of GSE was partitioned between 50 mL of water and 75 mL of ethyl acetate.
Evaporation of the organic phase produced 3.7 g of a residue that was subjected to centrifugal
partition chromatography on a Kromaton FCPC model A with a 1 L rot r. The solvent syste consiste
of thyl acetate-ethanol-water (10:1:10, v/v). After equilibration by shaking, the lower phase was
pumped into the rotor at 200 RPM. Next, the en re 3.7 g sample was dissolved in 30 mL of a 1:1
mixture of each phase and injec ed into the rotor, while the rotational speed was increased to 800 RPM.
F llowing sample injection, the upper phase was pumped into the rotor at 9 mL/min. The elu nt was
collected into test tubes in 20 mL increments. The band of 1 eluted in test tubes #37–53. After combining
and evaporating, this fraction produced 390 mg of 1 at 94% purity. The final purification was achieved
by preparative HPLC using a Waters 600 system with manual injection (Rheodyne 7125) and a YMC
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ODS-AQ 50 × 250 mm preparative column. The chromatography was carried out with a gradient of
8–15% acetonitrile with 0.5% acetic acid at 30 mL/min. Half of the 390 mg sample of 1 was injected per
run, and the main peak of 1 was collected. After evaporation and drying in vacuo, the total yield of 1
was 320 mg of a colorless solid with a purity of 99.7%.
3.3. Preparation of Samples for HPLC Analysis
Samples of GSEs were dissolved in 20% MeOH in water with a final concentration of 10 mg/mL,
and the samples were filtered through a 0.45 µm membrane before injection.
3.4. HPLC Conditions
HPLC chromatographic separation was achieved using a Hewlett Packard HP Series 1050 (Agilent
Technologies, Santa Clara, CA, USA) system equipped with an autosampler and DAD. A YMC-Pack
C18, 4.6 × 150 mm, S-5 µm, 120 Å column was used for all analyses. The mobile phase was composed
of acetonitrile and HPLC grade water. HPLC signals were monitored at 270 nm with a flow-rate of
1.0 mL/min. HP Chemstation A10.7 was used to control the operation of the system and perform data
analysis. The injection volume of all solutions was 5 µL. The gradient elution system consisted of water
with 5% acetonitrile and 0.1% trifluoroacetic acid (mobile phase A) and acetonitrile (mobile phase
B). At a flow rate of 1.0 mL/min, the following elution program was used: 0→ 15.0 min (5→ 25% B),
15.0→15.1 min (25→ 90% B), 15.1→ 17.0 min (90% B), 17.0→ 17.1 min (5% B), 17.1→ 24.0 min (5% B).
All analyses were carried out at 25 ◦C.
3.5. NMR, HRESIMS, and MS/MS Evaluation of 1
NMR spectra were obtained on a 300 MHz spectrometer (Bruker BioSpin, Rheinstetten, Germany)
operating at 300 MHz and 75.5 MHz, respectively, using standard pulse programs. Spectra were
recorded in methanol-d4 at 295 K and referenced to solvent signals at 3.31 (δH) and 49.00 ppm (δC)
(Figures S1 and S2).
The ESI-QTOF Compact (Bruker Daltonics, Bremen, Germany) was used for the HRESIMS
and MS/MS experiments. The instrument was calibrated with the tuning ESI-L mixture (Agilent
Technologies, Santa Clara, CA, USA). Analysis of the obtained mass spectra was carried out using Data
Analysis v4.2 software (Bruker Daltonics, Bremen, Germany). The main instrumental parameters were
as follows: scan range, 50–2200 m/z; dry gas, nitrogen; temperature, 180 ◦C; potential between the spray
needle and the orifice, 4.2 kV. ESI was operated in negative mode. The HRESIMS spectrum showed
an abundant [M−H]− ion at m/z 291.0883 (calcd. 291.0874 for C15H15O6), indicating the molecular
formula C15H16O6. The mass accuracy for 1 was within 4 ppm. In the MS/MS experiment, the negative
ion [M−H]− at m/z 291 was further fragmented at 25.0 eV, as shown in Figure 3.
3.6. Free-Radical Scavenging and Reducing Activity of 1 and Selected Phenols
All measurements were performed in triplicate using Spectrophotometer CE 3021 (CECIL
instruments, Cambridge, Great Britain).
3.6.1. ABTS Assay
Trolox™ (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) (Sigma-Aldrich,
Poznań,Poland) was used as the antioxidant standard. ABTS ((2,2’-azino-bis-(3-ethylbenzothiazoline-6-
sulfonic acid) and potassium persulfate (dipotassium peroxydisulfate) were obtained from
Sigma-Aldrich (Poznań, Poland). The Trolox solution was prepared in methanol at a final concentration
of 1.76 mg/mL, then diluted with deionized water to form known dilutions ranging from 0.05 mg/mL
to 0.44 mg/mL. Samples were dissolved in methanol at 1 mg/mL concentrations and then were further
diluted five times with deionized water.
Molecules 2019, 24, 2466 8 of 11
The assay was performed according to the method by Re et al. [27], with some modifications.
The ABTS salt (7 mmol) and K2S2O8 (2.45 mmol) solutions were combined in a volumetric ratio of 1:1.
The mixture was kept in the dark at room temperature for 16 h to produce the ABTS radical (ABTS•+).
Immediately before the measurement, the mixture containing the (ABTS•+) was diluted with water to
the absorbance of 0.7 at 734 nm.
Twenty microliters of each sample or the Trolox standard was added to the tube following the
2 mL of ABTS•+, and the resulting reaction mixture was vortexed. The absorbance was measured at
734 nm after a 6 min incubation at room temperature. Deionized water was used as a blank.
3.6.2. DPPH Assay
A solution of 8.0 mg of DPPH (1,1-diphenyl-2-picrylhydrazyl; Sigma-Aldrich, Poznań, Poland)
was dissolved in 20 mL of methanol. This solution was then stored in the dark for 2 h. Solutions of
selected phenols were prepared in methanol at 1 mg/mL.
Measurements were performed according to Brand-Williams et al. [28], with some modifications.
In six test-tubes, 0, 20, 40, 60, 80, and 100 µL of phenol samples were mixed with methanol up to
a volume of 100 µL. Later, 2 mL of methanol and 0.25 mL of the prepared DPPH solution were added to
each tube. The mixtures were vortexed and allowed to stand for 20 min in the dark at room temperature
(25 ◦C). Absorbance was then measured at 517 nm. Methanol was used as a blank.
3.6.3. FRAP Assay
FeSO4 × 7H2O was used for a calibration curve. The compound was dissolved in methanol and
diluted with water to obtain concentrations of 0.0125, 0.025, 0.05, 0.10, 0.15, 0.20, and 0.30 mg/mL.
From the phenol samples, 1 mg/mL methanolic solutions were prepared and diluted with water to
finally obtain seven concentrations: 0.1, 0.08, 0.06, 0.04, 0.03, 0.02, 0.01 mg/mL, respectively.
The assay was performed according to Benzie and Strain [29], with some modifications. The FRAP
working solution was prepared prior to the start of the analysis: 0.3 mol acetate buffer (pH 3.6), 0.01 mol
TPTZ (2,4,6-tripyridyl-s-triazine; Sigma-Aldrich, Poznań, Poland) in 0.04 mol HCl (POCH, Lublin,
Poland) and 0.02 M FeCl3 × 6H2O in water (iron (III) chloride hexahydrate; Chempur, Poland) were
mixed in a volumetric ratio of 10:1:1 and protected from light. Next, 75 µL of the phenol solutions
or FeSO4 × 7H2O solutions were mixed with 2.25 mL of the FRAP working solution and 225 µL of
water. The obtained mixtures were incubated at 37 ◦C for 30 min, and their absorbance was measured
at 593 nm. Deionized water with a FRAP solution was used as a blank.
3.7. Smooth Muscle Relaxant Assay
A 15 cm ileum segment was excised from the small intestine of male guinea pigs and immersed
into a Krebs solution (NaCl 120 mM, KCl 5.6 mM, MgCl2 2.2 mM, CaCl2 2.4 mM, NaHCO3 19 mM,
glucose 10 mM). After the first 5 cm length closest to the ileocecal junction was discarded, 2 cm
fragments were cut. Each segment of the ileum was placed in a 20 mL tissue organ bath system chamber
(Tissue Organ Bath System—750 TOBS, DMT, Aarhus, Denmark) filled with the Krebs solution at
37 ◦C, pH 7.4, with constant oxygenation (O2/CO2, 19:1). The tissues were stretched by closing the
clips between the metal rod and the force-displacement transducer. The preparations were allowed
to stabilize in the organ baths for 60 min under a resting tension of 1 g and were washed every
15 min with fresh Krebs solution [30]. To evaluate the response and mechanism of action after the
equilibration period, submaximal contraction induced by either histamine (2 µM), carbachol (100 µM),
or BaCl2 (0.03 M) was determined in the presence or absence of the tested compound (10 µM) [21].
The Committee for the Animal Welfare of the Pharmaceutical Faculty of Jagiellonian University allowed
usage of animal organs and tissues for the research (Document number 2018/09/01).
Contraction amplitudes were measured in at least six independent experiments.
Relaxing responses induced by the tested compound were assessed as a percentage of the maximum
contraction attained in control and expressed as the mean ± SEM. GraphPad Prism v5.0 software
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(GraphPad Software, San Diego, CA, USA) was used for data analysis, and the values were compared
using the Student’s t-test for paired data.
4. Conclusions
GSEs are used as one of the most common antioxidants in many dietary supplements and herbal
drugs. Processing and storage of grape seeds under non-GMP conditions may lead to contamination by
anaerobic bacteria, resulting in the reductive cleavage of the C-ring of flavan-3-ols, thereby producing
1. Our study indicates that 1 could serve as an important marker for the routine evaluation of the GSE
quality. We established that 1 significantly reduced guinea pig ileum contractions induced by histamine,
likely through blockage of the H1 histamine receptors. Consequences from the human intake of 1
on the relaxation of smooth muscles should be considered in the future. Additionally, as evidenced
by the performed assays, we want to underscore the antioxidant potential of 1, which exceeded the
antioxidant potential of its parent molecules.
Supplementary Materials: The following are available online at http://www.mdpi.com/1420-3049/24/13/2466/s1,
Figure S1: 1H-NMR spectrum of compound 1; Figure S2: 13C-NMR spectrum of compound 1.
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